NCT04377854Recruiting
Prognostic Value of BNP in MCS - a 25 Year Follow up Study
The Prognostic Value of proBNP in Patients Supported With Durable Mechanical Circulatory Assist Devices - a 25 Year Follow up Study.
Source: ClinicalTrials.gov · Last updated 5 May 2021 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
A biobank has been created to investigate the prognostic value of biomarkers (mainly BNP) in patients implanted with durable mechanical assist devices comparing patients with advanced HF supported by MCS with those who are transplanted and those who remain on optimal medical therapy. Patients will be followed up for 25 years after inclusion.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1000 (estimated)
- First submitted
- 3 May 2020
- Start date
- 18 Sept 2020
- Primary completion date
- 1 Aug 2045
- Lead sponsor
- Copenhagen University Hospital, Rigshospitalet
- Diseases
- Heart failure
- NCT number
- NCT04377854
What you commit to
- Study type: Observational
- Planned participants: 1000
- From 18 Sept 2020 to the primary completion date, 1 Aug 2045
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- No consent
Who the study is looking for
- All patients referred for evaluation for advanced HF treatment at the Rigshospital in Denmark
- Age\>18 years
Age in the registry: 18 years to - · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Rigshospitalet Coordinator of this site? Confirm its status | Copenhagen | Denmark | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.